Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow

NCT04594239 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Volume Loss in the Infraorbital Hollow Area

Interventions

DEVICE: Belotero Balance (+) Lidocaine, needle
DEVICE: Belotero Balance (+) Lidocaine, cannula
DEVICE: Untreated-control / delayed-treatment, needle
DEVICE: Untreated-control / delayed-treatment, cannulas

Sponsor

Merz North America, Inc.